Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Schrödinger, Inc. develops a physics-based computational platform for discovering new molecules in drug development and materials science. The company offers software solutions and also engages in drug discovery through internal programs and collaborations, positioning itself as a key player in transforming molecular discovery.
AI-generated summary. Not investment advice.